Psychedelic Revolution: Ibogaine Fast-Tracked Despite Heart Risks
President Trump signed an EO on April 18, 2026, directing accelerated federal review of psychedelics including Schedule I ibogaine for PTSD and opioid addiction. With RFK Jr., FDA Commissioner Makary, Joe Rogan, and Navy SEAL Marcus Luttrell present, the move includes national priority vouchers for three psychedelics and first-ever U.S.…
- → Mexico-based ibogaine clinics experience short-term demand surge from U.S. veterans awaiting domestic data, while U.S. researchers accelerate sourcing partnerships in Gabon.
- → Cross-state policy contagion: red-state legislatures fast-track university research programs, creating uneven regulatory patchwork that fragments insurance and telehealth strategies.
- +3 more →











